🔎 Trials Near Me

Akèy › Limfom › Ohio › Columbus

Etid klinik pou Limfom nan Columbus, OH

11 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Ap rekriteFaz 2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07015242

Epco, Zanu, Ritux for R/R FL or MZL

Ap rekriteFaz 2
  • The Ohio State University Wexner Medical Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06563596

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Ap rekriteFaz 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT04301076

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Ap rekriteFaz 2
  • The Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07221500

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon
  • Ohio State University, Columbus
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • The Ohio State University Wexner Medical Center James Cancer, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Ap rekriteFaz 1/2
  • Dren Investigational Site, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT05475925

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

Ap rekriteFaz 1
  • The Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Apr 24, 2026 · NCT06801002

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Ap rekriteFaz 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT07356245

HPC Offered for PRESERVE Expansion

Ap rekriteEtid obsèvasyon
  • The Ohio State University Medical Center, Columbus
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411

Etid Limfom nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.